Kiniksa Pharmaceuticals International, plc
KNSA
$76.75
-$1.08-1.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 80.66M | 73.06M | 59.01M | 35.92M | 4.79M |
| Total Depreciation and Amortization | 1.79M | 1.68M | 1.55M | 1.49M | 1.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 61.47M | 57.62M | 52.64M | 46.00M | 34.58M |
| Change in Net Operating Assets | 41.04M | 33.51M | 24.79M | 19.45M | 26.07M |
| Cash from Operations | 184.97M | 165.86M | 137.99M | 102.86M | 66.95M |
| Capital Expenditure | -2.13M | -1.63M | -1.57M | -1.13M | -457.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -236.94M | -167.74M | -187.43M | -51.76M | 3.98M |
| Cash from Investing | -239.07M | -169.37M | -188.99M | -52.89M | 3.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 48.80M | 43.96M | 40.75M | 34.90M | 28.05M |
| Repurchase of Common Stock | -11.06M | -7.63M | -7.73M | -7.39M | -5.75M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 37.74M | 36.33M | 33.02M | 27.51M | 22.30M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.36M | 32.82M | -17.99M | 77.48M | 92.77M |